ZA202001892B - Combined pharmaceutical formulation comprising dapagliflozin l-proline and metformin - Google Patents

Combined pharmaceutical formulation comprising dapagliflozin l-proline and metformin

Info

Publication number
ZA202001892B
ZA202001892B ZA2020/01892A ZA202001892A ZA202001892B ZA 202001892 B ZA202001892 B ZA 202001892B ZA 2020/01892 A ZA2020/01892 A ZA 2020/01892A ZA 202001892 A ZA202001892 A ZA 202001892A ZA 202001892 B ZA202001892 B ZA 202001892B
Authority
ZA
South Africa
Prior art keywords
dapagliflozin
metformin
proline
pharmaceutical formulation
combined pharmaceutical
Prior art date
Application number
ZA2020/01892A
Inventor
Jung Hyun Cho
Hyung Seo Kim
Taek Kwan Kwon
Yong Il Kim
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020180079614A external-priority patent/KR102369679B1/en
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of ZA202001892B publication Critical patent/ZA202001892B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
ZA2020/01892A 2017-09-29 2020-03-24 Combined pharmaceutical formulation comprising dapagliflozin l-proline and metformin ZA202001892B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20170126878 2017-09-29
KR1020180079614A KR102369679B1 (en) 2017-09-29 2018-07-09 Pharmaceutical combination comprising DAPAGLIFLOZIN L-PROLINE and METFORMIN
PCT/KR2018/011004 WO2019066359A2 (en) 2017-09-29 2018-09-18 Combined pharmaceutical formulation comprising dapagliflozin l-proline and metformin

Publications (1)

Publication Number Publication Date
ZA202001892B true ZA202001892B (en) 2023-06-28

Family

ID=65901595

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2020/01892A ZA202001892B (en) 2017-09-29 2020-03-24 Combined pharmaceutical formulation comprising dapagliflozin l-proline and metformin

Country Status (3)

Country Link
MX (1) MX2020002312A (en)
WO (1) WO2019066359A2 (en)
ZA (1) ZA202001892B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7919598B2 (en) * 2006-06-28 2011-04-05 Bristol-Myers Squibb Company Crystal structures of SGLT2 inhibitors and processes for preparing same
RS57756B1 (en) * 2009-11-13 2018-12-31 Astrazeneca Ab Bilayer tablet formulations
US9555001B2 (en) * 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
KR101526825B1 (en) * 2014-12-23 2015-06-08 주식회사 한독 Pharmaceutical Compositions for The Treatment of Diabetes
CN106924208A (en) * 2015-12-30 2017-07-07 深圳翰宇药业股份有限公司 A kind of compound Dapagliflozin Metformin Extended-release Tablets and preparation method thereof

Also Published As

Publication number Publication date
WO2019066359A3 (en) 2019-05-16
MX2020002312A (en) 2020-09-17
WO2019066359A2 (en) 2019-04-04

Similar Documents

Publication Publication Date Title
IL284835A (en) Pharmaceutical combination comprising tno155 and ribociclib
IL269061A (en) Pharmaceutical composition comprising selexipag
PL3412660T3 (en) Sulfonamide derivative and pharmaceutical composition containing same
EP3434285A4 (en) Pharmaceutical composition and use thereof
IL271226A (en) Pharmaceutical formulation
IL273339A (en) Griseofulvin compound and pharmaceutical use thereof
PL3521281T3 (en) 1-[(pyridin-3-yl-sulfonyl)-1h-pyrrol-3-yl]methanamine derivative and pharmaceutical composition and use thereof
ZA201807125B (en) Pharmaceutical composition of dapagliflozin
PL3658122T3 (en) Pharmaceutical composition comprising sacubitril and valsartan
FI3601277T3 (en) Pharmaceutical formulation
IL279877A (en) Ivosidenib forms and pharmaceutical compositions
EP3615064A4 (en) Enriched cellular compositions and therapeutic use
ZA202000959B (en) Adamantylmethylamine derivative and use thereof as pharmaceutical
IL275144A (en) Pharmaceutical formulation
ZA202001892B (en) Combined pharmaceutical formulation comprising dapagliflozin l-proline and metformin
SG11202100057TA (en) Composition comprising glycyrrhin and cosmetic and pharmaceutical uses thereof
EP3718543A4 (en) Pharmaceutical composition and use thereof
IL272080A (en) Peptide derivative and pharmaceutical composition containing same
IL264083A (en) Pharmaceutical composition comprising benzydamine
HK1254527A1 (en) Pharmaceutical formulation and use thereof
GB201713920D0 (en) Pharmaceutical compositions and uses thereof
GB201719873D0 (en) Pharmaceutical formulation
GB201604810D0 (en) Pharmaceutical compositions and uses